• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其伊斯坦布尔肺结核治疗结果影响因素的回顾性病例对照研究。

A retrospective case-control study, factors affecting treatment outcomes for pulmonary tuberculosis in istanbul, Turkey.

机构信息

Department of Pulmonology, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey.

Department of Pulmonology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey.

出版信息

Balkan Med J. 2013 Jun;30(2):204-10. doi: 10.5152/balkanmedj.2013.005. Epub 2013 Jun 1.

DOI:10.5152/balkanmedj.2013.005
PMID:25207101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4115984/
Abstract

BACKGROUND

Tuberculosis is a public health problem and its transmission is a threat to the community.

AIMS

The aim of this study was to determine the factors influencing the treatment outcomes and the effectiveness of the National Tuberculosis Program (NTP) in relation to the application of the directly observed treatment, short-course (DOTS) program in various sites in Istanbul, Turkey.

STUDY DESIGN

Case-Control Study.

METHODS

A case-control study was used, where cases and controls were randomly selected from the Turkish Tuberculosis National Database, which includes complete data on treatment outcomes for patients recorded in the database from January 1, 2006 to December 31, 2009 and had one year follow-up.

RESULTS

The case group was composed of 464 patients with adverse outcome, while the control group was composed of 441 patients who had been cured of disease. Factors associated with adverse treatment outcome were >65 years of age (OR: 3.39 (1.99-5.76)) ; male gender (OR:2.11 (1.49-2.99)); born outside Turkey (OR: 5.48 (2.13-14.04)); co-morbidity (OR: 1.85 (1.29-2.65)); bilateral radiologic lesions (OR: 2.07 (1.41-3.00); previous treatment history (OR: 3.99 (2.78-5.74)); 3(rd) month positive microscopy (OR: 4.96 (3.04-8.09)) and any H&R +/- others multidrug resistant (MDR) resistance (OR: 22.64 (6.92-74.08)). There was no association between the adverse treatment outcome and the application site of direct observation treatment, short course (DOTS) delivery and the supervisors.

CONCLUSION

Our findings indicate similar quality in DOTS application and supervision among patients with or without adverse treatment outcomes. However, patients with certain characteristics should be carefully monitored and aggressively treated.

摘要

背景

结核病是一个公共卫生问题,其传播对社区构成威胁。

目的

本研究旨在确定影响治疗结果的因素,以及土耳其伊斯坦布尔各地点实施直接观察治疗短期疗程(DOTS)方案对国家结核病规划(NTP)的效果。

研究设计

病例对照研究。

方法

采用病例对照研究,病例和对照均随机选自土耳其结核病国家数据库,该数据库包含了 2006 年 1 月 1 日至 2009 年 12 月 31 日期间记录在数据库中的治疗结果完整数据,并进行了为期 1 年的随访。

结果

病例组由 464 例不良结局患者组成,对照组由 441 例治愈的患者组成。与不良治疗结局相关的因素包括年龄>65 岁(OR:3.39(1.99-5.76));男性(OR:2.11(1.49-2.99));出生于土耳其境外(OR:5.48(2.13-14.04));合并症(OR:1.85(1.29-2.65));双侧放射学病变(OR:2.07(1.41-3.00));既往治疗史(OR:3.99(2.78-5.74));第 3 个月显微镜检查阳性(OR:4.96(3.04-8.09))和任何 H&R +/-其他耐多药(MDR)耐药(OR:22.64(6.92-74.08))。不良治疗结局与直接观察治疗短期疗程(DOTS)实施地点以及督导员之间无相关性。

结论

我们的研究结果表明,在具有或不具有不良治疗结局的患者中,DOTS 应用和监督质量相似。然而,具有某些特征的患者应密切监测并积极治疗。

相似文献

1
A retrospective case-control study, factors affecting treatment outcomes for pulmonary tuberculosis in istanbul, Turkey.土耳其伊斯坦布尔肺结核治疗结果影响因素的回顾性病例对照研究。
Balkan Med J. 2013 Jun;30(2):204-10. doi: 10.5152/balkanmedj.2013.005. Epub 2013 Jun 1.
2
Tuberculosis结核病
3
A registry-based cohort study of pulmonary tuberculosis treatment outcomes in Istanbul, Turkey.土耳其伊斯坦布尔基于登记的肺结核治疗结局队列研究。
Jpn J Infect Dis. 2013;66(2):115-20. doi: 10.7883/yoken.66.115.
4
[Tuberculosis in Asia].[亚洲的结核病]
Kekkaku. 2002 Oct;77(10):693-7.
5
An investigation into the relationship between region specific quality of life and adverse tuberculosis treatment outcomes in Istanbul, Turkey.土耳其伊斯坦布尔地区特定生活质量与结核病治疗不良结局之间关系的调查。
Rev Port Pneumol. 2014 Sep-Oct;20(5):248-53. doi: 10.1016/j.rppneu.2014.01.003. Epub 2014 Mar 24.
6
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南:肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
7
Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.“直接观察治疗短程化疗加强版”(DOTS-Plus)方案下耐多药结核病的治疗效果:已发表研究的系统评价与荟萃分析
Infect Dis Poverty. 2017 Jan 17;6(1):7. doi: 10.1186/s40249-016-0214-x.
8
[Tuberculosis incidence and primary drug resistance rates in young soldiers: data from 14 military hospitals in Turkey].年轻士兵中的结核病发病率及原发性耐药率:来自土耳其14家军队医院的数据
Mikrobiyol Bul. 2012 Jan;46(1):26-32.
9
The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome.耐多药结核病患者的治疗结果及影响治疗结局的因素。
Tuberk Toraks. 2009;57(4):383-92.
10
Control of tuberculosis by community health workers in Bangladesh.孟加拉国社区卫生工作者对结核病的控制
Lancet. 1997 Jul 19;350(9072):169-72. doi: 10.1016/S0140-6736(96)11311-8.

引用本文的文献

1
Determinants of unsuccessful tuberculosis treatment outcome in Southwest Ethiopia regional state public hospitals, 2022: a multi-center case control study.2022 年,埃塞俄比亚西南部地区州立公立医院结核病治疗结局失败的决定因素:一项多中心病例对照研究。
Front Public Health. 2024 Oct 22;12:1406211. doi: 10.3389/fpubh.2024.1406211. eCollection 2024.
2
Effects of diabetes mellitus on retreatment of Tuberculosis: A multi-centered case-control study from Bangladesh.糖尿病对结核病再治疗的影响:一项来自孟加拉国的多中心病例对照研究。
J Clin Tuberc Other Mycobact Dis. 2024 May 8;36:100450. doi: 10.1016/j.jctube.2024.100450. eCollection 2024 Aug.
3
The trend of tuberculosis case notification and predictors of unsuccessful treatment outcomes in Samdrup Jongkhar district, Bhutan: A fourteen-year retrospective study.不丹萨姆德鲁琼卡尔地区结核病病例通报趋势及治疗结果未成功的预测因素:一项十四年回顾性研究
Heliyon. 2021 Mar 25;7(3):e06573. doi: 10.1016/j.heliyon.2021.e06573. eCollection 2021 Mar.
4
Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis.结核病患者队列中死亡率危险因素的生存分析。
Can Respir J. 2020 Sep 5;2020:1654653. doi: 10.1155/2020/1654653. eCollection 2020.
5
Characteristics of Poor Tuberculosis Treatment Outcomes among Patients with Pulmonary Tuberculosis in Community Hospitals of Thailand.泰国社区医院肺结核患者中治疗结局不佳的特征。
Am J Trop Med Hyg. 2020 Mar;102(3):553-561. doi: 10.4269/ajtmh.19-0564.
6
Patient support for tuberculosis patients in low-incidence countries: A systematic review.低发病国家中结核病患者的患者支持:系统评价。
PLoS One. 2018 Oct 10;13(10):e0205433. doi: 10.1371/journal.pone.0205433. eCollection 2018.
7
Determinants of adverse treatment outcomes among patients treated under Revised National Tuberculosis Control Program in Wardha, India: Case-control study.印度瓦尔达修订后的国家结核病控制项目治疗患者不良治疗结果的决定因素:病例对照研究。
Med J Armed Forces India. 2018 Jul;74(3):241-249. doi: 10.1016/j.mjafi.2017.07.008. Epub 2017 Sep 1.
8
Evaluating treatment outcomes and durations among cases of smear-positive pulmonary tuberculosis in Yemen: a prospective follow-up study.评估也门涂片阳性肺结核病例的治疗效果和疗程:一项前瞻性随访研究。
J Pharm Policy Pract. 2017 Dec 1;10:36. doi: 10.1186/s40545-017-0124-8. eCollection 2017.
9
Magnitude and determinants of adverse treatment outcomes among tuberculosis patients registered under Revised National Tuberculosis Control Program in a Tuberculosis Unit, Wardha, Central India: A record-based cohort study.印度中部沃尔达结核病防治单位修订后的国家结核病控制规划登记的结核病患者不良治疗结局的严重程度及决定因素:一项基于记录的队列研究
J Epidemiol Glob Health. 2017 Jun;7(2):111-118. doi: 10.1016/j.jegh.2017.02.002. Epub 2017 Mar 18.

本文引用的文献

1
Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-study.与巴西亚马逊地区结核病治疗失败相关的因素:一项病例对照研究。
PLoS One. 2012;7(6):e39134. doi: 10.1371/journal.pone.0039134. Epub 2012 Jun 12.
2
Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study.芬兰肺外结核的治疗结果:一项队列研究。
BMC Public Health. 2010 Jul 6;10:399. doi: 10.1186/1471-2458-10-399.
3
Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.肺结核治疗期间痰液监测对预测结局的作用:系统评价和荟萃分析。
Lancet Infect Dis. 2010 Jun;10(6):387-94. doi: 10.1016/S1473-3099(10)70071-2.
4
Tuberculosis treatment adherence and fatality in Spain.西班牙的结核病治疗依从性和死亡率。
Respir Res. 2009 Dec 1;10(1):121. doi: 10.1186/1465-9921-10-121.
5
Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.在泰国,直接观察治疗与外国结核病患者中违约率降低有关。
Int J Tuberc Lung Dis. 2009 Feb;13(2):232-7.
6
Predicting tuberculosis treatment outcome in a low-incidence area.
Int J Tuberc Lung Dis. 2008 Dec;12(12):1441-8.
7
Risk factors for death among tuberculosis cases: analysis of European surveillance data.结核病病例死亡的危险因素:欧洲监测数据分析
Eur Respir J. 2008 Jun;31(6):1256-60. doi: 10.1183/09031936.00131107.
8
Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens.多药耐药对标准化治疗方案的结核病治疗结果的影响。
Am J Respir Crit Care Med. 2008 Aug 1;178(3):306-12. doi: 10.1164/rccm.200802-240OC. Epub 2008 May 29.
9
Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico.墨西哥恰帕斯州洛斯阿尔托斯地区与肺结核死亡率相关的人口统计学、卫生服务及社会经济因素
Int J Epidemiol. 2008 Aug;37(4):786-95. doi: 10.1093/ije/dyn089. Epub 2008 May 29.
10
Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.结核病患者治疗成功的相关因素:土耳其一家单中心的经验
Jpn J Infect Dis. 2008 Jan;61(1):25-30.